![Construction of competing endogenous RNA interaction network as prognostic markers in metastatic melanoma [PeerJ] Construction of competing endogenous RNA interaction network as prognostic markers in metastatic melanoma [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/12143/1/fig-3-full.png)
Construction of competing endogenous RNA interaction network as prognostic markers in metastatic melanoma [PeerJ]
![Predictive and on-treatment monitoring biomarkers in advanced melanoma: Moving toward personalized medicine - ScienceDirect Predictive and on-treatment monitoring biomarkers in advanced melanoma: Moving toward personalized medicine - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0305737218301592-gr1.jpg)
Predictive and on-treatment monitoring biomarkers in advanced melanoma: Moving toward personalized medicine - ScienceDirect
![SciELO - Brasil - Immunohistochemical assessment of E-cadherin, β-catenin, CEACAM-1 and PTEN: tumor progression markers in melanoma Immunohistochemical assessment of E-cadherin, β-catenin, CEACAM-1 and PTEN: tumor progression markers in melanoma SciELO - Brasil - Immunohistochemical assessment of E-cadherin, β-catenin, CEACAM-1 and PTEN: tumor progression markers in melanoma Immunohistochemical assessment of E-cadherin, β-catenin, CEACAM-1 and PTEN: tumor progression markers in melanoma](https://minio.scielo.br/documentstore/1678-4774/TvQRW5PSF7KzgcPwtzggfMp/a77905511b14e1f98c2bbca638ee763004d17a29.gif)
SciELO - Brasil - Immunohistochemical assessment of E-cadherin, β-catenin, CEACAM-1 and PTEN: tumor progression markers in melanoma Immunohistochemical assessment of E-cadherin, β-catenin, CEACAM-1 and PTEN: tumor progression markers in melanoma
![Diagnostic and Prognostic Biomarkers in Melanoma – JCAD | The Journal of Clinical and Aesthetic Dermatology Diagnostic and Prognostic Biomarkers in Melanoma – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/Weinstein-table1_June2014.jpg)
Diagnostic and Prognostic Biomarkers in Melanoma – JCAD | The Journal of Clinical and Aesthetic Dermatology
![Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells | Anticancer Research Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/37/9/5033/T2.medium.gif)
Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells | Anticancer Research
![Dermatopathology | Free Full-Text | Aberrant Expression of Immunohistochemical Markers in Malignant Melanoma: A Review Dermatopathology | Free Full-Text | Aberrant Expression of Immunohistochemical Markers in Malignant Melanoma: A Review](https://pub.mdpi-res.com/dermatopathology/dermatopathology-08-00040/article_deploy/html/images/dermatopathology-08-00040-g001.png?1627984389)
Dermatopathology | Free Full-Text | Aberrant Expression of Immunohistochemical Markers in Malignant Melanoma: A Review
![Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance - ScienceDirect Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610821006127-fx1.jpg)
Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance - ScienceDirect
![Standard melanoma-associated markers do not identify the MM127 metastatic melanoma cell line | Scientific Reports Standard melanoma-associated markers do not identify the MM127 metastatic melanoma cell line | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep24569/MediaObjects/41598_2016_Article_BFsrep24569_Fig1_HTML.jpg)
Standard melanoma-associated markers do not identify the MM127 metastatic melanoma cell line | Scientific Reports
![Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells | Anticancer Research Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/37/9/5033/F1.large.jpg)
Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells | Anticancer Research
![Diagnostic and Prognostic Biomarkers in Melanoma – JCAD | The Journal of Clinical and Aesthetic Dermatology Diagnostic and Prognostic Biomarkers in Melanoma – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/Weinstein-table4_June2014.jpg)